| |
| |
|
| Insider
Information: |
Frates James M |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
318,827 |
|
|
Indirect Shares
|
184,010 |
|
|
| Direct
Value |
$2,217,646 |
|
|
|
Indirect Value
|
$3,759,406 |
|
|
| Total
Shares |
502,837 |
|
|
| Total
Value |
$5,977,053 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alkermes Plc |
ALKS |
SVP, Alks Inc; CFO ALKS |
2020-05-14 |
91,828 |
2020-05-14 |
155,669 |
Premium* |
|
|
Sage Therapeutics, Inc. |
SAGE |
|
2021-06-16 |
1,035 |
2021-06-16 |
1,810 |
Premium* |
|
|
Amylyx Pharmaceuticals, Inc. |
AMLX |
|
2024-04-16 |
225,964 |
2024-04-16 |
26,531 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-09-15 |
4 |
AS |
$70.85 |
$1,421,972 |
D/D |
(20,000) |
48,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-12-14 |
4 |
AS |
$54.72 |
$1,368,133 |
D/D |
(25,000) |
112,342 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2016-12-07 |
4 |
AS |
$55.65 |
$1,335,632 |
D/D |
(23,731) |
112,342 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-07-14 |
4 |
AS |
$65.37 |
$1,315,860 |
D/D |
(20,000) |
48,713 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-05-06 |
4 |
AS |
$162.22 |
$1,297,760 |
D/D |
(8,000) |
4,235 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-08-15 |
4 |
AS |
$160.58 |
$1,284,640 |
D/D |
(8,000) |
2,535 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-10-13 |
4 |
AS |
$59.09 |
$1,195,516 |
D/D |
(20,000) |
51,357 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2013-12-16 |
4 |
AS |
$38.92 |
$1,189,197 |
D/D |
(30,437) |
90,514 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2013-12-17 |
4 |
AS |
$39.00 |
$1,186,915 |
D/D |
(30,437) |
85,514 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2018-05-08 |
4 |
AS |
$154.00 |
$1,078,000 |
D/D |
(7,000) |
5,000 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-12-10 |
4 |
AS |
$56.04 |
$1,057,984 |
D/D |
(18,870) |
77,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2017-11-29 |
4 |
AS |
$50.49 |
$1,057,249 |
D/D |
(20,932) |
144,039 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-03-16 |
4 |
AS |
$31.86 |
$1,036,459 |
D/D |
(32,500) |
1,509 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-03-16 |
4/A |
AS |
$31.86 |
$1,036,459 |
D/D |
(32,500) |
34,009 |
0 |
- |
|
| SAGE |
Sage Therapeutics, Inc. |
|
– • – |
2019-01-23 |
4 |
AS |
$134.81 |
$1,011,075 |
D/D |
(7,500) |
4,235 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2017-11-08 |
4 |
AS |
$47.58 |
$996,009 |
D/D |
(20,932) |
144,039 |
0 |
- |
|
| AMLX |
Amylyx Pharmaceuticals, I... |
Chief Financial Officer |
• – – |
2023-05-16 |
4 |
AS |
$26.93 |
$875,451 |
D/D |
(32,500) |
55,676 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP, Alks Inc; CFO ALKS |
• • – |
2018-06-12 |
4 |
AS |
$50.00 |
$842,179 |
D/D |
(16,842) |
37,234 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-09-24 |
4 |
AS |
$45.29 |
$724,640 |
D/D |
(16,000) |
44,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-11-10 |
4 |
AS |
$72.34 |
$723,395 |
D/D |
(10,000) |
49,857 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-08-27 |
4 |
AS |
$45.08 |
$721,301 |
D/D |
(16,000) |
44,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-02-03 |
4 |
AS |
$70.39 |
$708,306 |
D/D |
(10,000) |
77,162 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2014-09-10 |
4 |
AS |
$43.18 |
$690,826 |
D/D |
(16,000) |
44,225 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-08-11 |
4 |
AS |
$67.63 |
$679,747 |
D/D |
(10,000) |
48,713 |
0 |
- |
|
| ALKS |
Alkermes Plc |
SVP & CFO, Alkermes plc |
• • – |
2015-01-15 |
4 |
AS |
$66.55 |
$668,624 |
D/D |
(10,000) |
77,162 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
